BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21951695)

  • 21. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.
    Wilson BA; Aminova LR; Ponferrada VG; Ho M
    Infect Immun; 2000 Aug; 68(8):4531-8. PubMed ID: 10899852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
    Babb RC; Homer KA; Robbins J; Lax AJ
    PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation.
    Kloos B; Chakraborty S; Lindner SG; Noack K; Harre U; Schett G; Krämer OH; Kubatzky KF
    Cell Commun Signal; 2015 Sep; 13():40. PubMed ID: 26369790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auranofin Inhibits the Enzyme Activity of Pasteurella multocida Toxin PMT in Human Cells and Protects Cells from Intoxication.
    Carle S; Brink T; Orth JH; Aktories K; Barth H
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28098782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin.
    Orth JH; Blöcker D; Aktories K
    Biochemistry; 2003 May; 42(17):4971-7. PubMed ID: 12718539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G{alpha} proteins, G{alpha}q and G{alpha}12/13.
    Orth JH; Lang S; Taniguchi M; Aktories K
    J Biol Chem; 2005 Nov; 280(44):36701-7. PubMed ID: 16141214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome wide CRISPR screen for Pasteurella multocida toxin (PMT) binding proteins reveals LDL Receptor Related Protein 1 (LRP1) as crucial cellular receptor.
    Schoellkopf J; Mueller T; Hippchen L; Mueller T; Reuten R; Backofen R; Orth J; Schmidt G
    PLoS Pathog; 2022 Dec; 18(12):e1010781. PubMed ID: 36516199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin-independent inhibition of 3T3-L1 adipogenesis by Pasteurella multocida toxin: suppression of Notch1, stabilization of beta-catenin and pre-adipocyte factor 1.
    Aminova LR; Wilson BA
    Cell Microbiol; 2007 Oct; 9(10):2485-96. PubMed ID: 17581254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. involvement of Gq but not G11.
    Zywietz A; Gohla A; Schmelz M; Schultz G; Offermanns S
    J Biol Chem; 2001 Feb; 276(6):3840-5. PubMed ID: 11062245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pasteurella multocida toxin as a transporter of non-cell-permeating proteins.
    Bergmann S; Jehle D; Schwan C; Orth JH; Aktories K
    Infect Immun; 2013 Jul; 81(7):2459-67. PubMed ID: 23630953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Targets of
    Banu A; Lax AJ; Grigoriadis AE
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1.
    Wilson BA; Zhu X; Ho M; Lu L
    J Biol Chem; 1997 Jan; 272(2):1268-75. PubMed ID: 8995431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology of Pasteurella multocida toxin.
    Orth JH; Aktories K
    Curr Top Microbiol Immunol; 2012; 361():73-92. PubMed ID: 22371145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.
    Miyazawa M; Kitadokoro K; Kamitani S; Shime H; Horiguchi Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):906-8. PubMed ID: 16946476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pasteurella multocida toxin facilitates inositol phosphate formation by bombesin through tyrosine phosphorylation of G alpha q.
    Baldwin MR; Pullinger GD; Lax AJ
    J Biol Chem; 2003 Aug; 278(35):32719-25. PubMed ID: 12799383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.
    Hildebrand D; Heeg K; Kubatzky KF
    Infect Immun; 2011 Jan; 79(1):220-8. PubMed ID: 20956572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pasteurella multocida toxin: a new paradigm for the link between bacterial infection and cancer.
    Lax A
    Curr Top Microbiol Immunol; 2012; 361():131-44. PubMed ID: 22695919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.
    Wilson BA; Ho M
    FEBS J; 2011 Dec; 278(23):4616-32. PubMed ID: 21569202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of Pasteurella multocida toxin on Galpha(q) is persistent and independent of interaction with G-protein-coupled receptors.
    Orth JH; Lang S; Preuss I; Milligan G; Aktories K
    Cell Signal; 2007 Oct; 19(10):2174-82. PubMed ID: 17669624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.